RNAimmune

Gaithersburg, United States

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

$27.0M raised

Mar 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has RNAimmune raised?

RNAimmune has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in March 2022.

Who are RNAimmune's investors?

RNAimmune's investors include Sirnaomics, Terra Magnum Capital Partners, Rotating Boulder Fund, Smooth River.

Where is RNAimmune headquartered?

RNAimmune is headquartered in Gaithersburg, United States.

What does RNAimmune do?

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.

What stage is RNAimmune at?

RNAimmune is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 29, 2022.

MLA

"RNAimmune — Funding & Investors." VCBacked, March 29, 2022, https://www.vcbacked.co/company/rnaimmune. Accessed July 2, 2026.

APA

VCBacked. (2022). RNAimmune — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rnaimmune

Wikipedia (cite web)

{{cite web |title=RNAimmune — Funding & Investors |url=https://www.vcbacked.co/company/rnaimmune |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 29, 2022.